Pro Share Advisors LLC United Therapeutics Corp Transaction History

Pro Share Advisors LLC

  • $36.7 Billion
  • Q1 2024

A detailed history of Pro Share Advisors LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Pro Share Advisors LLC holds 5,589 shares of UTHR stock, worth $1.76 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,589
Previous 5,472 2.14%
Holding current value
$1.76 Million
Previous $1.2 Million 6.65%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024
BUY
$210.76 - $249.51 $24,658 - $29,192
117 Added 2.14%
5,589 $1.28 Million
Q4 2023

Feb 14, 2024
SELL
$214.88 - $256.94 $28,149 - $33,659
-131 Reduced 2.34%
5,472 $1.2 Million
Q3 2023

Nov 13, 2023
SELL
$211.82 - $248.24 $35,162 - $41,207
-166 Reduced 2.88%
5,603 $1.27 Million
Q2 2023

Aug 10, 2023
SELL
$205.19 - $232.99 $31,188 - $35,414
-152 Reduced 2.57%
5,769 $1.27 Million
Q1 2023

May 11, 2023
SELL
$212.99 - $276.17 $286,471 - $371,448
-1,345 Reduced 18.51%
5,921 $1.33 Million
Q4 2022

Feb 02, 2023
BUY
$205.95 - $280.43 $46,132 - $62,816
224 Added 3.18%
7,266 $2.02 Million
Q3 2022

Nov 04, 2022
BUY
$203.3 - $244.17 $57,533 - $69,100
283 Added 4.19%
7,042 $1.48 Million
Q2 2022

Aug 01, 2022
SELL
$174.81 - $241.14 $419,893 - $579,218
-2,402 Reduced 26.22%
6,759 $1.59 Million
Q1 2022

May 10, 2022
SELL
$166.16 - $213.96 $395,294 - $509,010
-2,379 Reduced 20.62%
9,161 $1.64 Million
Q4 2021

Feb 08, 2022
SELL
$184.32 - $216.08 $410,849 - $481,642
-2,229 Reduced 16.19%
11,540 $2.49 Million
Q3 2021

Nov 12, 2021
BUY
$179.86 - $214.88 $128,060 - $152,994
712 Added 5.45%
13,769 $2.54 Million
Q2 2021

Aug 13, 2021
BUY
$170.47 - $211.93 $447,313 - $556,104
2,624 Added 25.15%
13,057 $2.34 Million
Q1 2021

May 14, 2021
SELL
$153.94 - $174.85 $110,067 - $125,017
-715 Reduced 6.41%
10,433 $1.75 Million
Q4 2020

Feb 09, 2021
BUY
$101.87 - $151.79 $21,902 - $32,634
215 Added 1.97%
11,148 $1.69 Million
Q3 2020

Nov 13, 2020
BUY
$99.9 - $121.13 $26,473 - $32,099
265 Added 2.48%
10,933 $1.1 Million
Q2 2020

Aug 03, 2020
BUY
$92.74 - $125.82 $203,378 - $275,923
2,193 Added 25.88%
10,668 $1.29 Million
Q1 2020

May 15, 2020
SELL
$79.39 - $115.35 $459,509 - $667,645
-5,788 Reduced 40.58%
8,475 $804,000
Q4 2019

Feb 12, 2020
SELL
$78.31 - $95.34 $152,469 - $185,626
-1,947 Reduced 12.01%
14,263 $1.26 Million
Q3 2019

Nov 12, 2019
SELL
$74.85 - $85.99 $84,879 - $97,512
-1,134 Reduced 6.54%
16,210 $1.29 Million
Q2 2019

Aug 13, 2019
SELL
$76.06 - $120.81 $219,965 - $349,382
-2,892 Reduced 14.29%
17,344 $1.35 Million
Q1 2019

May 15, 2019
BUY
$107.15 - $126.84 $136,187 - $161,213
1,271 Added 6.7%
20,236 $2.38 Million
Q4 2018

Feb 14, 2019
SELL
$101.4 - $128.73 $400,631 - $508,612
-3,951 Reduced 17.24%
18,965 $2.07 Million
Q3 2018

Nov 14, 2018
SELL
$113.81 - $129.46 $16,616 - $18,901
-146 Reduced 0.63%
22,916 $2.93 Million
Q2 2018

Aug 13, 2018
SELL
$101.14 - $118.31 $172,645 - $201,955
-1,707 Reduced 6.89%
23,062 $2.61 Million
Q1 2018

May 14, 2018
SELL
$107.21 - $151.94 $367,301 - $520,546
-3,426 Reduced 12.15%
24,769 $2.78 Million
Q4 2017

Feb 14, 2018
SELL
$118.58 - $151.28 $11,858 - $15,128
-100 Reduced 0.35%
28,195 $4.17 Million
Q3 2017

Nov 13, 2017
BUY
$114.6 - $136.81 $124,341 - $148,438
1,085 Added 3.99%
28,295 $3.32 Million
Q2 2017

Aug 11, 2017
BUY
N/A
27,210
27,210 $3.53 Million

Others Institutions Holding UTHR

# of Institutions
561
Shares Held
43.1M
Call Options Held
501K
Put Options Held
529K
View Full List

About UNITED THERAPEUTICS Corp

UTHR Quotes by TradingView
  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $14.3B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email